Business 1 • 8 Aug 2026 ProLogium and Translational Development Acquisition Corp Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination ProLogium’s 2022 $50M capital infusion and SPAC merger with TDAC propelled its advanced battery expansion, culminating in a successful public listing.